<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
  <meta http-equiv="x-ua-compatible" content="ie=edge">
  <link rel="stylesheet" href="css/bootstrap.min.css">
  <link rel="stylesheet" type="text/css" href="css/style.css">
  <title>MtSite</title>
</head>
<body>

<div class=" mybackground myjumbotron mb-0" id="jumbotron">
  <div class="mycontainer">
    <h1>Protin kinase</h1>
    <p>Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.</p>
  </div>
</div>

<nav class="nav navbar navbar-dark navbar-fixed-top navbar-expand-md" style="background-color: #032C4D">
    <button class="navbar-toggler" type="button" 
      data-toggle="collapse" data-target="#myTogglerNav"
      aria-controls="myTogglerNav"
      aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div class="collapse navbar-collapse" id="myTogglerNav">
    <div class="navbar-nav ml-auto">
        <a class="nav-item nav-link active" href="index.html">Home</a>

        <div class="dropdown">
          <a class="nav-item nav-link dropdown-toggle" data-toggle="dropdown" 
          id="MissionDropdown1" aria-haspopup="true" aria-expended="false" href="#">My Interests</a>
            <div class="dropdown-menu" aria-labelledby="MissionDropdown1">
              <a class="dropdown-item" href="#">Bootstrap</a>
              <a class="dropdown-item" href="#">Sass</a>
              <a class="dropdown-item" href="#">Node JS</a>
            </div>
        </div><!-- cdropdown -->
        <div class="dropdown">
          <a class="nav-item nav-link dropdown-toggle" data-toggle="dropdown" 
          id="MissionDropdown2" aria-haspopup="true" aria-expended="false" href="#">Drug Discovery</a>
            <div class="dropdown-menu" aria-labelledby="MissionDropdown2">
              <a class="dropdown-item" href="protin_kinase.html">Protein Kinase</a>
              <a class="dropdown-item" href="AKT_PKB_signaling.html">Akt/PKB signaling pathway</a>
              <a class="dropdown-item" href="mTOR_inhibitors.html">mTOR inhibitors</a>
			  <a class="dropdown-item" href="analgesics.html">Analgesics</a>
			  <a class="dropdown-item" href="G_protein_coupled_receptor.html">GPCRs</a>
            </div>
        </div><!-- cdropdown -->
        <div class="dropdown">
          <a class="nav-item nav-link dropdown-toggle" data-toggle="dropdown" 
          id="MissionDropdown3" aria-haspopup="true" aria-expended="false" href="#">Photography</a>
            <div class="dropdown-menu" aria-labelledby="MissionDropdown3">
              <a class="dropdown-item" href="#">Mission1</a>
              <a class="dropdown-item" href="#">Mission2</a>
              <a class="dropdown-item" href="#">Mission3</a>
            </div>
        </div><!-- cdropdown -->
      <a class="nav-item nav-link" href="#">Testimonials</a>
    </div><!-- navbar nav-->
    </div><!-- collapse-->
</nav>	

<div class="container-fluid">
	<div class="row">  
	<div class="col-md-2 bg-dark">
	
    </div><!-- col-2 -->
		
	<div class="col-md-8">
		<section class="text-justify">
   <div class="panel panel-default">
   <div class="panel-body">

    <h1>Protein  kinase A</h1>
	<h2>1.0 Background</h2><p>Protein kinase A, more precisely known as adenosine 3',5'-monophosphate  (cyclic AMP)-dependent protein kinase was discovered by chemists H. Fischer and  Edwin G. Krebs in 1968. They won the Nobel Prize in Physiology or Medicine in  1992 for their work on phosphorylation and dephosphorylation and how it is  related to protein kinase A activity. PKA is one of the most widely researched  protein kinases, in part because of its uniqueness; out of 540 different  protein kinase genes that make up for human kinome, only one other protein  kinase, <a href="https://en.wikipedia.org/wiki/Casein_kinase_2" title="Casein kinase 2">Casein kinase 2</a>, is known to exist in a  physiological tetrameric complex. The diversity of mammalian PKA subunits was  realized after Dr. Stan Knight and others identified possible four subunit C  genes and presence of four R subunit genes. In 1991, Susan Taylor and et al.  crystallized the PKA Cα subunit which revealed the bi-lobe structure of the  protein kinase core for the very first time, providing a blueprint for all the  other protein kinases in a genome ('the kinome').</p>
   
   <h2>2.0 Structure</h2><p>The PKA holoenzyme exists as a tetramer, although higher order  structures form in cells, where PKA is targeted to specific components. The  classical PKA holoenzyme structure consists of two regulatory subunits and two  catalytic subunits. The catalytic subunit contains the active site, a series of  canonical residues found in <a href="https://en.wikipedia.org/wiki/Protein_kinases" title="Protein kinases">protein  kinases</a> that bind and hydrolyse ATP and a domain to bind the regulatory  subunit. The regulatory subunit has domains to bind to cyclic AMP, a domain  that interacts with catalytic subunit and an auto inhibitory domain. There are  two major forms of regulatory subunit; RI and RII.</p>
   
   <h2>3.0 Mechanism</h2><h3>3.1 Activation</h3><p>PKA is also commonly known as cAMP-dependent protein kinase, because it  has traditionally been thought to be activated through release of the catalytic  subunits when levels of the second messenger cAMP rise in response to a variety  of signals. However, recent studies evaluating the intact holoenzyme complexes,  including regulatory AKAP-bound signalling complexes, have suggested that the  local sub cellular activation of the catalytic activity of PKA might proceed  without physical separation of the regulatory and catalytic components,  especially at physiological concentrations of cAMP. In contrast, experimentally  induced supra physiological concentrations of cAMP are able to cause separation  of the holoenzymes, and release of the catalytic subunits. Extracellular  hormones such as glucagon and epinephrine begin an intracellular signalling  cascade that triggers protein kinase A activation by first binding to a <a href="https://en.wikipedia.org/wiki/G_protein%E2%80%93coupled_receptor" title="G protein–coupled receptor">G protein–coupled receptor</a> (GPCR) on the  target cell. When a GPCR is activated by its extracellular ligand, a <a href="https://en.wikipedia.org/wiki/Conformational_change" title="Conformational change">conformational change</a> is induced in the  receptor that is transmitted to an attached intracellular heterotrimeric G  protein complex by <a href="https://en.wikipedia.org/wiki/Protein_dynamics#Global_flexibility:_multiple_domains" title="Protein dynamics">protein domain dynamics</a>. The <a href="https://en.wikipedia.org/wiki/Gs_alpha_subunit" title="Gs alpha subunit">Gs  alpha subunit</a> of the stimulated G protein complex exchanges GDP for GTP and  is released from the complex. The activated Gs alpha subunit binds to and  activates an enzyme called <a href="https://en.wikipedia.org/wiki/Adenylyl_cyclase" title="Adenylyl cyclase">adenylyl  cyclase</a>, which, in turn, catalyzes the conversion of ATP into cyclic  adenosine monophosphate (cAMP) – which directly increases cAMP levels. Four  cAMP molecules are able to bind to the two R-subunits, this is done by two cAMP  molecules binding to each of the two cAMP binding sites (CNB-B and CNB-A) which  produces a conformational change in the regulatory subunits on a PKA enzyme  causing the subunits to detach and unleashing the two (now activated) catalytic  subunits. Once released from their inhibitory Regulatory subunit, the catalytic  subunits can go on to phosphorylate a huge number of other proteins in the  minimal substrate context Arg-Arg-X-Ser/Thr., although they are still subject  to other layers of regulation, include modulation by the heat stable  pseudosubstrate inhibitor of PKA, termed PKI.The mechanisms of further effects may be divided into direct protein  phosphorylation and protein synthesis:<img width="350" height="285" src="images/img/mechanism.png" alt="PKA mechanism" style="float: left; margin: 0px 20px 10px 0px;">
    <ul>
     <li>Below is a list of the steps involved in PKA  activation:</li>
     <li>Cytosolic <a href="https://en.wikipedia.org/wiki/Cyclic_adenosine_monophosphate" title="Cyclic adenosine monophosphate">cAMP</a> increases</li>
     <li>Two cAMP molecules bind to each PKA regulatory  subunit</li>
     <li>The regulatory subunits move out of the active  sites of the catalytic subunits and the R2C2 complex dissociates</li>
     <li>The free catalytic subunits interact with  proteins to phosphorylate Ser or Thr residues.</li>
   </ul>
   </p>
   
  <h3>3.2 Catalysis</h3><p>The liberated catalytic subunits can then catalyze the transfer of ATP  terminal phosphates to <a href="https://en.wikipedia.org/wiki/Protein" title="Protein">protein</a> <a href="https://en.wikipedia.org/wiki/Substrate_(biochemistry)" title="Substrate (biochemistry)">substrates</a> at <a href="https://en.wikipedia.org/wiki/Serine" title="Serine">serine</a>, or <a href="https://en.wikipedia.org/wiki/Threonine" title="Threonine">threonine</a> <a href="https://en.wikipedia.org/wiki/Amino_acid" title="Amino acid">residues</a>.  This <a href="https://en.wikipedia.org/wiki/Phosphorylation" title="Phosphorylation">phosphorylation</a> usually results in a change in  activity of the substrate. Since PKAs are present in a variety of cells and act  on different substrates, PKA regulation and cAMP regulation are involved in  many different pathways. In direct protein phosphorylation, PKA directly either  increases or decreases the activity of a protein. In protein synthesis, PKA  first directly activates <a href="https://en.wikipedia.org/wiki/CREB" title="CREB">CREB</a>, which binds the <a href="https://en.wikipedia.org/wiki/CAMP_response_element" title="CAMP response element">cAMP response element</a>, altering the <a href="https://en.wikipedia.org/wiki/Transcription_(genetics)" title="Transcription (genetics)">transcription</a> and therefore the synthesis  of the protein. In general, this mechanism takes more time (hours to days).</p>
  
 <h3>3.3 Phosphorylation mechanism</h3><p>The Serine/Threonine residue of the substrate peptide is orientated in  such a way that the hydroxyl group faces towards the gamma phosphate group of  the bound ATP molecule. Both the substrate, ATP, and two Mg2+ ions form  intensive contacts with the catalytic subunit of PKA. In the active  conformation, the C helix packs against the N-terminal lobe and the Aspartate  residue of the conserved DFG motif chelates the Mg2+ ions, assisting in  positioning the ATP substrate. The triphosphate group of ATP points out of the  adenosine pocket for transfer of gamma-phosphate to the Serine/Threonine of the  peptide substrate. There are several conserved residues, include Glutamate (E)  91 and Lysine (K) 72, that mediate the positioning of alpha- and beta-phosphate  groups. The hydroxyl group the peptide substrate's Serine/Threonine attacks the  gamma phosphate group at the phosphorus via an SN2 nucleophilic reaction, which  results in the transfer of the terminal phosphate to the peptide substrate and  cleavage of the phosphodiester bond between the beta-phosphate and the  gamma-phosphate groups. PKA acts as a model for understanding <a href="https://en.wikipedia.org/wiki/Protein_kinase" title="Protein kinase">protein  kinase</a> biology, with the position of the conserved residues helping to  distinguish the active <a href="https://en.wikipedia.org/wiki/Protein_kinase" title="Protein kinase">protein kinase</a> and inactive <a href="https://en.wikipedia.org/wiki/Pseudokinase" title="Pseudokinase">pseudokinase</a> members of the human kinome.</p>
 
<h3>3.4 Inactivation</h3><p class="clearfix"><img src="images/img/cAMP.png" alt="cAMP" width="149" height="149" style="float: left; margin: 0px 20px 0px 0px;">Downregulation of protein kinase A occurs by a feedback mechanism uses a number  of cAMP hydrolyzing <a href="https://en.wikipedia.org/wiki/Phosphodiesterase" title="Phosphodiesterase">phosphodiesterase</a> enzymes, which is one of the  substrates activated by the kinase. Phosphodiesterase quickly converts cAMP to  AMP, thus reducing the amount of cAMP that can activate protein kinase A. PKA  is also regulated by a complex series of phosphorylation events, which can  include modification by autophosphorylation, and phosphorylation by regulatory  kinases, such as PDK1 <a href="https://en.wikipedia.org/wiki/Protein_kinase_A#cite_note-Byrne_DP_2016-8"></a>
Thus, PKA is controlled, in part, by the levels <a href="https://en.wikipedia.org/wiki/Cyclic_adenosine_monophosphate" title="Cyclic adenosine monophosphate">cAMP</a>. Also, the catalytic subunit  itself can be down-regulated by phosphorylation.</p>
  
<h3>3.5 Anchorage</h3><p>The regulatory subunit dimer of PKA is important for localizing the kinase  inside the cell. The dimerization and docking (D/D) domain of the dimer binds  to the A-kinase binding (AKB) domain of <a href="https://en.wikipedia.org/wiki/A-kinase_anchoring_protein" title="A-kinase anchoring protein">A-kinase anchor protein</a> (AKAP). The  AKAPs localize PKA to various locations (e.g., plasma membrane, mitochondria,  etc.) within the cell. AKAPs bind many other signaling proteins, creating a  very efficient signaling hub at a certain location within the cell. For  example, an AKAP located near the nucleus of a heart muscle cell would bind  both PKA and phosphodiesterase (hydrolyzes cAMP), which allows the cell to  limit the productivity of PKA, since the catalytic subunit is activated once  cAMP binds to the regulatory subunits.</p>
  
<h2>4.0 Function</h2><p>PKA phosphorylates <a href="https://en.wikipedia.org/wiki/Proteins" title="Proteins">proteins</a> that have the motif Arginine-Arginine-X-Serine  exposed, in turn (de)activating the proteins. As protein expression varies from  cell type to cell type, the proteins that are available for phosphorylation  will depend upon the cell in which PKA is present. Thus, the effects of PKA  activation vary with <a href="https://en.wikipedia.org/wiki/Cell_type" title="Cell type">cell type</a>:</p>
  
   <table class="mytable" border="1" cellpadding="0">
     <tr>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Cell_type" title="Cell type">Cell type</a></p></td>
       <td><p align="center">Organ/system</p></td>
       <td><p align="center">Stimulators<br>
         <a href="https://en.wikipedia.org/wiki/Ligands" title="Ligands">ligands</a> → <a href="https://en.wikipedia.org/wiki/Gs_alpha_subunit" title="Gs alpha subunit">Gs</a>-<a href="https://en.wikipedia.org/wiki/G_protein-coupled_receptor" title="G protein-coupled receptor">GPCRs</a><br>
         or <a href="https://en.wikipedia.org/wiki/Phosphodiesterase_inhibitor" title="Phosphodiesterase inhibitor">PDE inhibitors</a></p></td>
       <td><p align="center">Inhibitors<br>
         ligands → <a href="https://en.wikipedia.org/wiki/Gi_alpha_subunit" title="Gi alpha subunit">Gi</a>-<a href="https://en.wikipedia.org/wiki/G_protein-coupled_receptor" title="G protein-coupled receptor">GPCRs</a><br>
         or <a href="https://en.wikipedia.org/wiki/Phosphodiesterase" title="Phosphodiesterase">PDE</a> stimulators</p></td>
       <td><p align="center">Effects</p></td>
     </tr>
     <tr>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Adipocyte" title="Adipocyte">adipocyte</a></p></td>
       <td></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Epinephrine" title="Epinephrine">epinephrine</a> → <a href="https://en.wikipedia.org/wiki/Beta-adrenergic_receptor" title="Beta-adrenergic receptor">β-adrenergic receptor</a><br>
         <a href="https://en.wikipedia.org/wiki/Glucagon" title="Glucagon">glucagon</a> → <a href="https://en.wikipedia.org/wiki/Glucagon_receptor" title="Glucagon receptor">Glucagon receptor</a></p></td>
       <td></td>
       <td><p align="center">enhance <a href="https://en.wikipedia.org/wiki/Lipolysis" title="Lipolysis">lipolysis</a><br>
         stimulate <a href="https://en.wikipedia.org/wiki/Lipase" title="Lipase">lipase</a><a href="https://en.wikipedia.org/wiki/Protein_kinase_A#cite_note-Rang172-12">[11]</a></p></td>
     </tr>
     <tr>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Myocyte" title="Myocyte">myocyte</a> (<a href="https://en.wikipedia.org/wiki/Skeletal_muscle" title="Skeletal muscle">skeletal    muscle</a>)</p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Muscular_system" title="Muscular system">muscular    system</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Epinephrine" title="Epinephrine">epinephrine</a> → <a href="https://en.wikipedia.org/wiki/Beta-adrenergic_receptor" title="Beta-adrenergic receptor">β-adrenergic receptor</a></p></td>
       <td></td>
       <td><p align="center">produce <a href="https://en.wikipedia.org/wiki/Glucose" title="Glucose">glucose</a><br>
         stimulate <a href="https://en.wikipedia.org/wiki/Glycogenolysis" title="Glycogenolysis">glycogenolysis</a><br>
         phosphorylate <a href="https://en.wikipedia.org/wiki/Glycogen_phosphorylase" title="Glycogen phosphorylase">glycogen phosphorylase</a> via <a href="https://en.wikipedia.org/wiki/Phosphorylase_kinase" title="Phosphorylase kinase">phosphorylase kinase</a> (activating it)<br>
         phosphorylate <a href="https://en.wikipedia.org/wiki/Acetyl-CoA_carboxylase" title="Acetyl-CoA carboxylase">Acetyl-CoA carboxylase</a> (inhibiting it)<br>
         inhibit <a href="https://en.wikipedia.org/wiki/Glycogenesis" title="Glycogenesis">glycogenesis</a><br>
         phosphorylate <a href="https://en.wikipedia.org/wiki/Glycogen_synthase" title="Glycogen synthase">glycogen synthase</a> (inhibiting it)<br>
         stimulate <a href="https://en.wikipedia.org/wiki/Glycolysis" title="Glycolysis">glycolysis</a><br>
         phosphorylate <a href="https://en.wikipedia.org/wiki/Phosphofructokinase_2" title="Phosphofructokinase 2">phosphofructokinase 2</a> (stimulating it,    cardiomyocytes only)</p></td>
     </tr>
     <tr>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Myocyte" title="Myocyte">myocyte</a> (<a href="https://en.wikipedia.org/wiki/Cardiac_muscle" title="Cardiac muscle">cardiac    muscle</a>)</p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Cardiovascular" title="Cardiovascular">cardiovascular</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a> → <a href="https://en.wikipedia.org/wiki/Beta-adrenergic_receptor" title="Beta-adrenergic receptor">β-adrenergic receptor</a></p></td>
       <td></td>
       <td><p align="center">sequester Ca2+ in <a href="https://en.wikipedia.org/wiki/Sarcoplasmic_reticulum" title="Sarcoplasmic reticulum">sarcoplasmic reticulum</a><br>
         phosphorylates <a href="https://en.wikipedia.org/wiki/Phospholamban" title="Phospholamban">phospholamban</a></p></td>
     </tr>
     <tr>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Myocyte" title="Myocyte">myocyte</a> (<a href="https://en.wikipedia.org/wiki/Smooth_muscle" title="Smooth muscle">smooth    muscle</a>)</p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Cardiovascular" title="Cardiovascular">cardiovascular</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Beta-2_adrenergic_receptor#Agonists" title="Beta-2 adrenergic receptor">β2 adrenergic agonists</a> → <a href="https://en.wikipedia.org/wiki/Beta-2_adrenergic_receptor" title="Beta-2 adrenergic receptor">β-2 adrenergic receptor</a><br>
         <a href="https://en.wikipedia.org/wiki/Histamine" title="Histamine">histamine</a> → <a href="https://en.wikipedia.org/wiki/Histamine_H2_receptor" title="Histamine H2 receptor">Histamine H2 receptor</a><br>
         <a href="https://en.wikipedia.org/wiki/Prostacyclin" title="Prostacyclin">prostacyclin</a> → <a href="https://en.wikipedia.org/wiki/Prostacyclin_receptor" title="Prostacyclin receptor">prostacyclin receptor</a><br>
         <a href="https://en.wikipedia.org/wiki/Prostaglandin_D2" title="Prostaglandin D2">Prostaglandin    D2</a> → <a href="https://en.wikipedia.org/wiki/Prostaglandin_D2_receptor" title="Prostaglandin D2 receptor">PGD2 receptor</a><br>
         <a href="https://en.wikipedia.org/wiki/Prostaglandin_E2" title="Prostaglandin E2">Prostaglandin    E2</a> → <a href="https://en.wikipedia.org/wiki/Prostaglandin_E2_receptor" title="Prostaglandin E2 receptor">PGE2 receptor</a><br>
         <a href="https://en.wikipedia.org/wiki/Vasoactive_intestinal_peptide" title="Vasoactive intestinal peptide">VIP</a> → <a href="https://en.wikipedia.org/wiki/Vasoactive_intestinal_peptide_receptor" title="Vasoactive intestinal peptide receptor">VIP receptor</a><br>
         L-<a href="https://en.wikipedia.org/wiki/Arginine" title="Arginine">Arginine</a> → <a href="https://en.wikipedia.org/wiki/Imidazoline_receptor" title="Imidazoline receptor">imidazoline</a> and <a href="https://en.wikipedia.org/wiki/Alpha-2_adrenergic_receptor" title="Alpha-2 adrenergic receptor">α2 receptor</a>? (<a href="https://en.wikipedia.org/wiki/Gi_alpha_subunit" title="Gi alpha subunit">Gi</a>-coupled)</p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Muscarinic_agonist" title="Muscarinic agonist">muscarinic agonists</a>, e.g. <a href="https://en.wikipedia.org/wiki/Acetylcholine" title="Acetylcholine">acetylcholine</a> → <a href="https://en.wikipedia.org/wiki/Muscarinic_acetylcholine_receptor_M2" title="Muscarinic acetylcholine receptor M2">muscarinic receptor M2</a><br>
         <a href="https://en.wikipedia.org/wiki/Neuropeptide_Y" title="Neuropeptide Y">NPY</a> → <a href="https://en.wikipedia.org/wiki/NPY_receptor" title="NPY receptor">NPY    receptor</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Vasodilation" title="Vasodilation">Vasodilation</a></p></td>
     </tr>
     <tr>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Hepatocyte" title="Hepatocyte">hepatocyte</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Liver" title="Liver">liver</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Epinephrine" title="Epinephrine">epinephrine</a> → <a href="https://en.wikipedia.org/wiki/Beta-adrenergic_receptor" title="Beta-adrenergic receptor">β-adrenergic receptor</a><br>
         <a href="https://en.wikipedia.org/wiki/Glucagon" title="Glucagon">glucagon</a> → <a href="https://en.wikipedia.org/wiki/Glucagon_receptor" title="Glucagon receptor">Glucagon receptor</a></p></td>
       <td></td>
       <td><p align="center">produce <a href="https://en.wikipedia.org/wiki/Glucose" title="Glucose">glucose</a><br>
         stimulate <a href="https://en.wikipedia.org/wiki/Glycogenolysis" title="Glycogenolysis">glycogenolysis</a><br>
         phosphorylate <a href="https://en.wikipedia.org/wiki/Glycogen_phosphorylase" title="Glycogen phosphorylase">glycogen phosphorylase</a> (activating it)<br>
         phosphorylate <a href="https://en.wikipedia.org/wiki/Acetyl-CoA_carboxylase" title="Acetyl-CoA carboxylase">Acetyl-CoA carboxylase</a> (inhibiting it)<br>
         inhibit <a href="https://en.wikipedia.org/wiki/Glycogenesis" title="Glycogenesis">glycogenesis</a><br>
         phosphorylate <a href="https://en.wikipedia.org/wiki/Glycogen_synthase" title="Glycogen synthase">glycogen synthase</a> (inhibiting it)<br>
         stimulate <a href="https://en.wikipedia.org/wiki/Gluconeogenesis" title="Gluconeogenesis">gluconeogenesis</a><br>
         phosphorylate <a href="https://en.wikipedia.org/wiki/Fructose_2,6-bisphosphatase" title="Fructose 2,6-bisphosphatase">fructose 2,6-bisphosphatase</a> (stimulating    it)<br>
         inhibit <a href="https://en.wikipedia.org/wiki/Glycolysis" title="Glycolysis">glycolysis</a><br>
         phosphorylate <a href="https://en.wikipedia.org/wiki/Phosphofructokinase-2" title="Phosphofructokinase-2">phosphofructokinase-2</a> (inactivating it)<br>
         phosphorylate <a href="https://en.wikipedia.org/wiki/Fructose_2,6-bisphosphatase" title="Fructose 2,6-bisphosphatase">fructose 2,6-bisphosphatase</a> (stimulate it)<br>
         phosphorylate <a href="https://en.wikipedia.org/wiki/Pyruvate_kinase" title="Pyruvate kinase">pyruvate    kinase</a> (inhibiting it)</p></td>
     </tr>
     <tr>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Neuron" title="Neuron">neurons</a> in <a href="https://en.wikipedia.org/wiki/Nucleus_accumbens" title="Nucleus accumbens">nucleus accumbens</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Nervous_system" title="Nervous system">nervous    system</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Dopamine" title="Dopamine">dopamine</a> → <a href="https://en.wikipedia.org/wiki/Dopamine_receptor" title="Dopamine receptor">dopamine receptor</a></p></td>
       <td></td>
       <td><p align="center">Activate <a href="https://en.wikipedia.org/wiki/Reward_system" title="Reward system">reward    system</a></p></td>
     </tr>
     <tr>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Principal_cell" title="Principal cell">principal    cells</a> in <a href="https://en.wikipedia.org/wiki/Kidney" title="Kidney">kidney</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Kidney" title="Kidney">kidney</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Vasopressin" title="Vasopressin">Vasopressin</a> → <a href="https://en.wikipedia.org/wiki/Arginine_vasopressin_receptor_2" title="Arginine vasopressin receptor 2">V2 receptor</a><br>
         <a href="https://en.wikipedia.org/wiki/Theophylline" title="Theophylline">theophylline</a> (<a href="https://en.wikipedia.org/wiki/Phosphodiesterase_inhibitor" title="Phosphodiesterase inhibitor">PDE inhibitor</a>)</p></td>
       <td></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Exocytosis" title="Exocytosis">exocytosis</a> of <a href="https://en.wikipedia.org/wiki/Aquaporin_2" title="Aquaporin 2">aquaporin    2</a> to <a href="https://en.wikipedia.org/wiki/Apical_membrane" title="Apical membrane">apical membrane</a>.<br>
         synthesis of aquaporin 2<br>
         phosphorylation of aquaporin 2    (stimulating it)</p></td>
     </tr>
     <tr>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Thick_ascending_limb_cell" title="Thick ascending limb cell">Thick ascending limb cell</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Kidney" title="Kidney">kidney</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Vasopressin" title="Vasopressin">Vasopressin</a> → <a href="https://en.wikipedia.org/wiki/Arginine_vasopressin_receptor_2" title="Arginine vasopressin receptor 2">V2 receptor</a></p></td>
       <td></td>
       <td><p align="center">stimulate <a href="https://en.wikipedia.org/wiki/Na-K-2Cl_symporter" title="Na-K-2Cl symporter">Na-K-2Cl symporter</a> (perhaps only minor effect)</p></td>
     </tr>
     <tr>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Cortical_collecting_tubule_cell" title="Cortical collecting tubule cell">Cortical collecting tubule cell</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Kidney" title="Kidney">kidney</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Vasopressin" title="Vasopressin">Vasopressin</a> → <a href="https://en.wikipedia.org/wiki/Arginine_vasopressin_receptor_2" title="Arginine vasopressin receptor 2">V2 receptor</a></p></td>
       <td></td>
       <td><p align="center">stimulate <a href="https://en.wikipedia.org/wiki/Epithelial_sodium_channel" title="Epithelial sodium channel">Epithelial sodium channel</a> (perhaps only minor effect)</p></td>
     </tr>
     <tr>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Inner_medullary_collecting_duct_cell" title="Inner medullary collecting duct cell">Inner medullary collecting duct cell</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Kidney" title="Kidney">kidney</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Vasopressin" title="Vasopressin">Vasopressin</a> → <a href="https://en.wikipedia.org/wiki/Arginine_vasopressin_receptor_2" title="Arginine vasopressin receptor 2">V2 receptor</a></p></td>
       <td></td>
       <td><p align="center">stimulate <a href="https://en.wikipedia.org/wiki/Urea_transporter_1" title="Urea transporter 1">urea transporter 1</a><br>
         <a href="https://en.wikipedia.org/wiki/Urea_transporter_1" title="Urea transporter 1">urea transporter 1</a> exocytosis</p></td>
     </tr>
     <tr>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Proximal_convoluted_tubule_cell" title="Proximal convoluted tubule cell">proximal convoluted tubule cell</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Kidney" title="Kidney">kidney</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Parathyroid_hormone" title="Parathyroid hormone">PTH</a> → <a href="https://en.wikipedia.org/wiki/PTH_receptor_1" title="PTH receptor 1">PTH    receptor 1</a></p></td>
       <td></td>
       <td><p align="center">Inhibit <a href="https://en.wikipedia.org/wiki/NHE3" title="NHE3">NHE3</a> → ↓H+ secretion</p></td>
     </tr>
     <tr>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Juxtaglomerular_cell" title="Juxtaglomerular cell">juxtaglomerular cell</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Kidney" title="Kidney">kidney</a></p></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Adrenergic_agonists" title="Adrenergic agonists">adrenergic agonists</a> → <a href="https://en.wikipedia.org/wiki/%CE%92-receptor" title="Β-receptor">β-receptor</a><br>
         agonists → <a href="https://en.wikipedia.org/wiki/Alpha-2_adrenergic_receptor" title="Alpha-2 adrenergic receptor">α2 receptor</a><br>
         <a href="https://en.wikipedia.org/wiki/Dopamine" title="Dopamine">dopamine</a> → <a href="https://en.wikipedia.org/wiki/Dopamine_receptor" title="Dopamine receptor">dopamine receptor</a><br>
         <a href="https://en.wikipedia.org/wiki/Glucagon" title="Glucagon">glucagon</a> → <a href="https://en.wikipedia.org/wiki/Glucagon_receptor" title="Glucagon receptor">glucagon receptor</a></p></td>
       <td></td>
       <td><p align="center"><a href="https://en.wikipedia.org/wiki/Renin" title="Renin">renin</a> secretion</p></td>
     </tr>
   </table>
   
   <h3>4.1 In adipocytes and hepatocytes</h3><p><a href="https://en.wikipedia.org/wiki/Adrenaline" title="Adrenaline">Adrenaline</a> and <a href="https://en.wikipedia.org/wiki/Glucagon" title="Glucagon">glucagon</a> affect the activity of protein kinase A by changing the levels of cAMP in a  cell via the G-protein mechanism, using <a href="https://en.wikipedia.org/wiki/Adenylate_cyclase" title="Adenylate cyclase">adenylate  cyclase</a>. Protein kinase A acts to phosphorylate many enzymes important in  metabolism. For example, protein kinase A phosphorylates <a href="https://en.wikipedia.org/wiki/Acetyl-CoA_carboxylase" title="Acetyl-CoA carboxylase">acetyl-CoA carboxylase</a> and <a href="https://en.wikipedia.org/wiki/Pyruvate_dehydrogenase" title="Pyruvate dehydrogenase">pyruvate dehydrogenase</a>. Such covalent  modification has an inhibitory effect on these enzymes, thus inhibiting <a href="https://en.wikipedia.org/wiki/Lipogenesis" title="Lipogenesis">lipogenesis</a> and promoting net <a href="https://en.wikipedia.org/wiki/Gluconeogenesis" title="Gluconeogenesis">gluconeogenesis</a>. Insulin, on the other hand,  decreases the level of phosphorylation of these enzymes, which instead promotes  lipogenesis. Recall that gluconeogenesis does not occur in myocytes.</p>
   
   <h3>4.2 In nucleus accumbens neurons</h3><p>PKA helps transfer/translate the <a href="https://en.wikipedia.org/wiki/Dopamine" title="Dopamine">dopamine</a> signal  into cells in the <a href="https://en.wikipedia.org/wiki/Nucleus_accumbens" title="Nucleus accumbens">nucleus accumbens</a>, which mediates reward,  motivation, and <a href="https://en.wikipedia.org/wiki/Salience_(neuroscience)" title="Salience (neuroscience)">task salience</a>. The vast majority of reward  perception involves neuronal activation in the nucleus accumbens, some examples  of which include sex, recreational drugs, and food. Protein Kinase A signal  transduction pathway helps in modulation of ethanol consumption and its  sedative effects. A mouse study reports that mice with genetically reduced  cAMP-PKA signalling results into less consumption of ethanol and are more  sensitive to its sedative effects.In skeletal muscle Protein Kinase A is directed to specific sub cellular locations after  tethering to Protein kinase A anchoring proteins (AKAPs). Sarcoplasmic  Reticulum Ca2+ release channel or Ryanodine receptor (Ryr) co-localizes with  the muscle AKAP. RyR phosphorylation and efflux of Ca 2+ is increased by  localisation of PKA at RyR by mAKP.</p>
   
   <h3>4.3 In memory formatiom</h3><p>PKA has always been considered important in formation of a memory.  Reductions in expression activity of DCO (PKA catalytic subunit encoding gene)  can cause severe learning disabilities, middle term memory and short-term  memory. Long term memory is dependent on the CREB transcription factor,  regulated by PKA. A study done on drosophila reported that an increase in PKA  activity can affect short term memory. However, a decrease in PKA activity by  24% inhibited learning abilities and a decrease by 16% affected both learning  ability and memory retention. Formation of a normal memory is highly sensitive  to PKA levels.</p>		
			
   <h1>Protein  kinase B</h1>
   <p>Protein  kinase B (PKB), also known as Akt, is a <a href="https://en.wikipedia.org/wiki/Serine/threonine-specific_protein_kinase" title="Serine/threonine-specific protein kinase">serine/threonine-specific protein kinase</a> that plays a key role in multiple  cellular processes such as <a href="https://en.wikipedia.org/wiki/Glucose_metabolism" title="Glucose metabolism">glucose  metabolism</a>, <a href="https://en.wikipedia.org/wiki/Apoptosis" title="Apoptosis">apoptosis</a>, <a href="https://en.wikipedia.org/wiki/Cell_proliferation" title="Cell proliferation">cell  proliferation</a>,  transcription and <a href="https://en.wikipedia.org/wiki/Cell_migration" title="Cell migration">cell  migration</a>.</p>
   <h2>1.0  Family members – Isoforms</h2>
   <p><a href="https://en.wikipedia.org/wiki/Akt1" title="Akt1">Akt1</a> is involved in cellular survival pathways, by inhibiting <a href="https://en.wikipedia.org/wiki/Apoptosis" title="Apoptosis">apoptotic</a> processes. Akt1 is also able to induce <a href="https://en.wikipedia.org/wiki/Protein_synthesis" title="Protein synthesis">protein synthesis</a> pathways, and is therefore a key signaling  protein in the cellular pathways that lead to skeletal muscle hypertrophy, and  general tissue growth. Mouse model with complete deletion of Akt1 manifests  growth retardation and increased spontaneous apoptosis in tissues such as  testes and thymus.  Since it  can block apoptosis, and thereby promote cell survival, Akt1 has been  implicated as a major factor in many types of cancer. Akt (now also called  Akt1) was originally identified as the <a href="https://en.wikipedia.org/wiki/Oncogene" title="Oncogene">oncogene</a> in the transforming <a href="https://en.wikipedia.org/wiki/Retrovirus" title="Retrovirus">retrovirus</a>, AKT8. <a href="https://en.wikipedia.org/wiki/Akt2" title="Akt2">Akt2</a> is an important signaling molecule in the <a href="https://en.wikipedia.org/wiki/Insulin_signal_transduction_pathway_and_regulation_of_blood_glucose" title="Insulin signal transduction pathway and regulation of blood glucose">insulin signaling pathway</a>. It is required to induce glucose  transport. In a mouse which is null for Akt1 but normal for Akt2, glucose  homeostasis is unperturbed, but the animals are smaller, consistent with a role  for Akt1 in growth. In contrast, mice which do not have Akt2, but have normal  Akt1, have mild growth deficiency and display a <a href="https://en.wikipedia.org/wiki/Diabetes" title="Diabetes">diabetic</a> phenotype (<a href="https://en.wikipedia.org/wiki/Insulin_resistance" title="Insulin resistance">insulin  resistance</a>), again  consistent with the idea that Akt2 is more specific for the <a href="https://en.wikipedia.org/wiki/Insulin_receptor" title="Insulin receptor">insulin receptor</a> signaling pathway. Akt isoforms are  overexpressed in a variety of human tumors, and, at the genomic level, are  amplified in gastric adenocarcinomas (Akt1), ovarian (Akt2), pancreatic (Akt2)  and breast (Akt2) cancer. The role of <a href="https://en.wikipedia.org/wiki/Akt3" title="Akt3">Akt3</a> is less clear, though it appears to be predominantly expressed in the  brain. It has been reported that mice lacking Akt3 have small brains.</p>

   <h2>2.0  Name</h2>
   <p>The name Akt does not refer  to its function. The &quot;Ak&quot; in Akt was a temporary classification name  for a mouse bred and maintained by <a href="http://www.nap.edu/read/2201/chapter/9#167">Jacob Furth</a> that developed spontaneous thymic lymphomas. The  &quot;t&quot; stands for '<a href="https://en.wikipedia.org/wiki/Thymoma" title="Thymoma">thymoma</a>'; the letter was added when a  transforming retrovirus was isolated from the Ak strain, which was termed  &quot;Akt-8&quot;. When the oncogene encoded in this virus was discovered, it  was termed v-Akt. Thus, the later identified human analogues were named  accordingly.</p>

   <h2>3.0  Regulation</h2>
   <h3>3.1  Binding phospholipids</h3>
   <p>Akt possesses a <a href="https://en.wikipedia.org/wiki/Protein_domain" title="Protein domain">protein domain</a> known as a PH domain, or <a href="https://en.wikipedia.org/wiki/Pleckstrin_homology_domain" title="Pleckstrin homology domain">Pleckstrin  Homology domain</a>, named  after <a href="https://en.wikipedia.org/wiki/Pleckstrin" title="Pleckstrin">Pleckstrin</a>, the protein in which it was first  discovered. This domain binds to <a href="https://en.wikipedia.org/wiki/Phosphatidylinositol" title="Phosphatidylinositol">phosphoinositides</a> with high affinity. In the case of the PH  domain of Akt, it binds either PIP3 (<a href="https://en.wikipedia.org/wiki/Phosphatidylinositol_(3,4,5)-trisphosphate" title="Phosphatidylinositol (3,4,5)-trisphosphate">phosphatidylinositol (3,4,5)-trisphosphate</a>, PtdIns(3,4,5)<em>P</em>3) or  PIP2 (<a href="https://en.wikipedia.org/wiki/Phosphatidylinositol_(3,4)-bisphosphate" title="Phosphatidylinositol (3,4)-bisphosphate">phosphatidylinositol (3,4)-bisphosphate</a>, PtdIns(3,4)<em>P</em>2). This  is useful for control of cellular signaling because the di-phosphorylated  phosphoinositide <a href="https://en.wikipedia.org/wiki/PtdIns(4,5)P2" title="PtdIns(4,5)P2">PIP2</a> is only phosphorylated by the family of  enzymes, PI 3-kinases (<a href="https://en.wikipedia.org/wiki/Phosphoinositide_3-kinase" title="Phosphoinositide 3-kinase">phosphoinositide  3-kinase</a> or PI3-K), and  only upon receipt of chemical messengers which tell the cell to begin the  growth process. For example, PI 3-kinases may be activated by a <a href="https://en.wikipedia.org/wiki/GPCR" title="GPCR">G protein coupled receptor</a> or <a href="https://en.wikipedia.org/wiki/Tyrosine_kinase" title="Tyrosine kinase">receptor tyrosine kinase</a> such as the <a href="https://en.wikipedia.org/wiki/Insulin_receptor" title="Insulin receptor">insulin receptor</a>. Once activated, PI 3-kinase phosphorylates PIP2  to form PIP3.</p>

   <h3>3.2  Phosphorylation</h3>
   <p>Once correctly positioned at  the membrane via binding of <a href="https://en.wikipedia.org/wiki/PIP3" title="PIP3">PIP3</a>, Akt can then be phosphorylated by its  activating kinases, phosphoinositide dependent kinase 1 (<a href="https://en.wikipedia.org/wiki/PDPK1" title="PDPK1">PDPK1</a> at threonine 308) and the mammalian target of rapamycin complex 2 (<a href="https://en.wikipedia.org/wiki/MTORC2" title="MTORC2">mTORC2</a> at serine 473), first by mTORC2. mTORC2 therefore functionally acts as the  long-sought PDK2 molecule, although other molecules, including <a href="https://en.wikipedia.org/wiki/Integrin-linked_kinase" title="Integrin-linked kinase">integrin-linked  kinase</a> (ILK) and  mitogen-activated protein kinase-activated protein kinase-2 (<a href="https://en.wikipedia.org/wiki/MAPKAPK2" title="MAPKAPK2">MAPKAPK2</a>) can also serve as PDK2. Phosphorylation by mTORC2 stimulates the  subsequent phosphorylation of Akt by PDPK1. Activated Akt can then go on  to activate or deactivate its myriad substrates (e.g. <a href="https://en.wikipedia.org/wiki/MTOR" title="MTOR">mTOR</a>) via its kinase activity. Besides being a downstream effector of PI  3-kinases, Akt can also be activated in a PI 3-kinase-independent manner. <a href="https://en.wikipedia.org/wiki/TNK2" title="TNK2">ACK1</a> or <a href="https://en.wikipedia.org/wiki/TNK2" title="TNK2">TNK2</a>, a non-receptor tyrosine kinase, phosphorylates  Akt at its tyrosine 176 residue, leading to its activation in PI  3-kinase-independent manner. Studies have suggested that <a href="https://en.wikipedia.org/wiki/Cyclic_adenosine_monophosphate" title="Cyclic adenosine monophosphate">cAMP</a>-elevating agents  could also activate Akt through <a href="https://en.wikipedia.org/wiki/Protein_kinase_A" title="Protein kinase A">protein kinase A</a> (PKA) in the presence of insulin.</p>

   <h3>3.3  Ubiquitination</h3>
   <p>Akt is normally <a href="https://en.wikipedia.org/wiki/Phosphorylated" title="Phosphorylated">phosphorylated</a> at position T450 in the turn motif when Akt is  translated. If Akt is not phosphorylated at this position, Akt does not fold in  the right way. The T450-non-phosphorylated misfolded Akt is <a href="https://en.wikipedia.org/wiki/Ubiquitinated" title="Ubiquitinated">ubiquitinated</a> and degraded by the <a href="https://en.wikipedia.org/wiki/Proteasome" title="Proteasome">proteasome</a>. Akt is also phosphorylated at T308 and S473  during <a href="https://en.wikipedia.org/wiki/IGF-1" title="IGF-1">IGF-1</a> response, and the resulting polyphosphorylated  Akt is ubiquitinated partly by <a href="https://en.wikipedia.org/wiki/E3_ligase" title="E3 ligase">E3 ligase</a> <a href="https://en.wikipedia.org/wiki/NEDD4" title="NEDD4">NEDD4</a>. Most of the ubiquitinated-phosphorylated-Akt is degraded by the  proteasome, while a small amount of phosphorylated-Akt translocates to the nucleus  in a ubiquitination-dependent way to phosphorylate its substrate. A  cancer-derived mutant Akt (E17K) is more readily ubiquitinated and  phosphorylated than the wild type Akt. The ubiquitinated-phosphorylated-Akt  (E17K) translocates more efficiently to the nucleus than the wild type Akt.  This mechanism may contribute to E17K-Akt-induced cancer in humans.</p>

   <h3>3.4  Lipid phosphatases and PIP3</h3>
   <p>PI3K-dependent Akt  activation can be regulated through the <a href="https://en.wikipedia.org/wiki/Tumor_suppressor_gene" title="Tumor suppressor gene">tumor  suppressor</a> <a href="https://en.wikipedia.org/wiki/PTEN_(gene)" title="PTEN (gene)">PTEN</a>, which works essentially as the opposite of <a href="https://en.wikipedia.org/wiki/PI3K" title="PI3K">PI3K</a> mentioned above. PTEN acts as a <a href="https://en.wikipedia.org/wiki/Phosphatase" title="Phosphatase">phosphatase</a> to dephosphorylate <a href="https://en.wikipedia.org/wiki/PIP3" title="PIP3">PIP3</a> back to <a href="https://en.wikipedia.org/wiki/PIP2" title="PIP2">PIP2</a>. This removes the membrane-localization factor  from the <a href="https://en.wikipedia.org/wiki/Akt" title="Akt">Akt</a> signaling pathway. Without this localization, the  rate of <a href="https://en.wikipedia.org/wiki/Akt" title="Akt">Akt</a> activation decreases significantly, as do all of  the downstream pathways that depend on <a href="https://en.wikipedia.org/wiki/Akt" title="Akt">Akt</a> for activation.<a href="https://en.wikipedia.org/wiki/PIP3" title="PIP3">PIP3</a> can also be de-phosphorylated at the &quot;5&quot; position by the SHIP  family of inositol phosphatases, <a href="https://en.wikipedia.org/wiki/INPP5D" title="INPP5D">SHIP1</a> and <a href="https://en.wikipedia.org/wiki/INPPL1" title="INPPL1">SHIP2</a>. These poly-phosphate inositol phosphatases  dephosphorylate <a href="https://en.wikipedia.org/wiki/PIP3" title="PIP3">PIP3</a> to form <a href="https://en.wikipedia.org/wiki/PIP2" title="PIP2">PIP2</a>.</p>

   <h3>3.5  Protein phosphatases</h3>
   <p>The phosphatases in the <a href="https://en.wikipedia.org/wiki/PHLPP" title="PHLPP">PHLPP</a> family, <a href="https://en.wikipedia.org/wiki/PHLPP" title="PHLPP">PHLPP1</a> and <a href="https://en.wikipedia.org/wiki/PHLPP2" title="PHLPP2">PHLPP2</a> have been shown to directly de-phosphorylate, and therefore inactivate, distinct  Akt isoforms. PHLPP2 dephosphorylates Akt1 and Akt3, whereas PHLPP1 is specific  for Akt 2 and Akt3.</p>

   <h2>4.0  Function</h2>
   <p>Akt regulates cellular  survival<a href="https://en.wikipedia.org/wiki/Protein_kinase_B#cite_note-pmid15784165-16"></a> and <a href="https://en.wikipedia.org/wiki/Metabolism" title="Metabolism">metabolism</a> by binding and regulating many downstream  effectors, e.g. <a href="https://en.wikipedia.org/wiki/NF-%CE%BAB" title="NF-κB">Nuclear Factor-κB</a>, Bcl-2 family proteins, master lysosomal  regulator <a href="https://en.wikipedia.org/wiki/TFEB" title="TFEB">TFEB</a> and murine double minute 2 (<a href="https://en.wikipedia.org/wiki/MDM2" title="MDM2">MDM2</a>).</p>

   <h3>4.1  Cell survival</h3>    
   <p><img src="images/img/Signal_transduction_pathways_svg.png"  alt="signal transduction" width="755" height="607" class="img-responsive" style="display: block; margin:auto; margin-bottom: 15px">Akt could promote growth  factor-mediated cell survival both directly and indirectly. <a href="https://en.wikipedia.org/wiki/Bcl-2-associated_death_promoter" title="Bcl-2-associated death promoter">BAD</a> is a  pro-apoptotic protein of the <a href="https://en.wikipedia.org/wiki/Bcl-2" title="Bcl-2">Bcl-2</a> family. Akt could phosphorylate BAD on Ser136, which makes BAD dissociate  from the Bcl-2/Bcl-X complex and lose the pro-apoptotic function. Akt could  also activate <a href="https://en.wikipedia.org/wiki/NF-%CE%BAB" title="NF-κB">NF-κB</a> via regulating <a href="https://en.wikipedia.org/wiki/I%CE%BAB_kinase" title="IκB kinase">IκB kinase</a> (IKK), thus result in transcription of  pro-survival genes.</p>
					
   <h3>4.2  Cell cycle</h3>
   <p>Akt is known to play a role  in the <a href="https://en.wikipedia.org/wiki/Cell_cycle" title="Cell cycle">cell cycle</a>. Under various circumstances, activation  of Akt was shown to overcome cell cycle arrest in G1 and G2 phases.  Moreover, activated Akt may enable proliferation and survival of cells that  have sustained a potentially mutagenic impact and, therefore, may contribute to  acquisition of mutations in other genes.</p>

   <h3>4.3  Metabolism</h3>
   <p>Akt2 is required for the  insulin-induced translocation of glucose transporter 4 (<a href="https://en.wikipedia.org/wiki/GLUT4" title="GLUT4">GLUT4</a>) to the <a href="https://en.wikipedia.org/wiki/Plasma_membrane" title="Plasma membrane">plasma  membrane</a>. Glycogen  synthase kinase 3 (<a href="https://en.wikipedia.org/wiki/GSK-3" title="GSK-3">GSK-3</a>) could be inhibited upon phosphorylation  by Akt, which results in increase of glycogen synthesis. GSK3 is also involved  in <a href="https://en.wikipedia.org/wiki/Wnt_signalling_pathway" title="Wnt signalling pathway">Wnt</a> signaling cascade, so Akt might be also  implicated in the Wnt pathway. Still unknown role in <a href="https://en.wikipedia.org/wiki/Hepatitis_C_virus" title="Hepatitis C virus">HCV</a> induced <a href="https://en.wikipedia.org/wiki/Steatosis" title="Steatosis">steatosis</a>.</p>

   <h3>4.4  Lysosomal biogenesis and autophagy</h3>
   <p>Akt regulates <a href="https://en.wikipedia.org/wiki/TFEB" title="TFEB">TFEB</a>, a master controller of lysosomal biogenesis, by direct phosphorylation at  serine 467. Phosphorylated TFEB is excluded from the nucleus and less active.  Pharmacological inhibition of Akt promotes nuclear translocation of <a href="https://en.wikipedia.org/wiki/TFEB" title="TFEB">TFEB</a>, lysosomal biogenesis and autophagy.</p>

   <h3>4.5  Angiogenesis</h3>
   <p>Akt1 has also been  implicated in <a href="https://en.wikipedia.org/wiki/Angiogenesis" title="Angiogenesis">angiogenesis</a> and tumor development. Although  deficiency of Akt1 in mice inhibited physiological angiogenesis, it enhanced  pathological angiogenesis and tumor growth associated with matrix abnormalities  in skin and blood vessels.</p>

   <h2>5.0  Clinical relevance</h2>
   <p>Akt is associated with tumor  cell survival, proliferation, and invasiveness. The activation of Akt is also  one of the most frequent alterations observed in human cancer and tumor cells.  Tumor cells that have constantly active Akt may depend on Akt for survival.  Therefore, understanding Akt and its pathways is important for the creation of  better therapies to treat cancer and tumor cells. A mosaic-activating mutation  (c. 49G→A, p.Glu17Lys) in AKT1 is associated with the Proteus Syndrome, which  causes overgrowth of skin, connective tissue, brain and other tissues.</p>

   <h3>5.1  AKT inhibitors</h3>
   <p>Because of the Akt functions  above, Akt inhibitors may treat cancers such as <a href="https://en.wikipedia.org/wiki/Neuroblastoma" title="Neuroblastoma">neuroblastoma</a>. Some Akt inhibitors have undergone clinical  trials. In 2007 <a href="https://en.wikipedia.org/w/index.php?title=VQD-002&action=edit&redlink=1" title="VQD-002 (page does not exist)">VQD-002</a> had a phase I  trial. In 2010 <a href="https://en.wikipedia.org/wiki/Perifosine" title="Perifosine">Perifosine</a> reached phase II. but it failed phase III  in 2012.<a href="https://en.wikipedia.org/wiki/Miltefosine" title="Miltefosine">Miltefosine</a> is approved for <a href="https://en.wikipedia.org/wiki/Leishmaniasis" title="Leishmaniasis">leishmaniasis</a> and under investigation for other indications  including HIV.
   AKT is now thought to be the  &quot;key&quot; for cell entry by <a href="https://en.wikipedia.org/wiki/HSV-1" title="HSV-1">HSV-1</a> and <a href="https://en.wikipedia.org/wiki/Herpes_simplex_virus_2" title="Herpes simplex virus 2">HSV-2</a> (herpes virus: oral and genital,  respectively). Intracellular <a href="https://en.wikipedia.org/wiki/Calcium_in_biology" title="Calcium in biology">calcium</a> release by the cell allows for entry by  the herpes virus; the virus activates AKT, which in turn causes the release of  calcium. Treating the cells with AKT inhibitors before virus exposure leads to  a significantly lower rate of infection. <a href="https://en.wikipedia.org/wiki/MK-2206" title="MK-2206">MK-2206</a> reported phase 1 results for advanced solid tumors in 2011, and  subsequently has undergone numerous phase II studies for a wide variety of  cancer types.In 2013 <a href="https://en.wikipedia.org/wiki/AZD5363" title="AZD5363">AZD5363</a> reported phase I results regarding solid tumors with a study of AZD5363  with <a href="https://en.wikipedia.org/wiki/Olaparib" title="Olaparib">olaparib</a> reporting in 2016. A new type of Akt inhibitor  has been discovered. <a href="https://en.wikipedia.org/wiki/Ipatasertib" title="Ipatasertib">Ipatasertib</a> is in phase II trials for breast cancer.</p>

   <h3>5.2  Decreased AKT can cause deleterious effects</h3>
   <p>AKT activation is associated  with many malignancies; however, a research group from <a href="https://en.wikipedia.org/wiki/Massachusetts_General_Hospital" title="Massachusetts General Hospital">Massachusetts General Hospital</a> and <a href="https://en.wikipedia.org/wiki/Harvard_University" title="Harvard University">Harvard  University</a> unexpectedly  observed a converse role for AKT and one of its downstream effector <a href="https://en.wikipedia.org/wiki/FOXO" title="FOXO">FOXOs</a> in <a href="https://en.wikipedia.org/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">acute  myeloid leukemia</a> (AML).  They claimed that low levels of AKT activity associated with elevated levels of  FOXOs are required to maintain the function and immature state of <a href="https://en.wikipedia.org/wiki/Cancer_stem_cell" title="Cancer stem cell">leukemia-initiating cells</a> (LICs). FOXOs are active, implying  reduced Akt activity, in ∼40% of AML patient samples regardless of  genetic subtype; and either activation of Akt or compound deletion of FoxO1/3/4  reduced leukemic cell growth in a mouse model.</p>

   <h3>5.3  Hyperactivation of AKT can cause deleterious effects</h3>
   <p>Two recent studies show that  AKT1 is involved in Juvenile Granulosa Cell tumors (JGCT). In-frame  duplications in the pleckstrin-homology domain (PHD) of the protein were found  in more than 60% of JGCTs occurring in girls under 15 years of age.  Interestingly, the JGCTs without duplications carried point mutations affecting  highly conserved residues. The mutated proteins carrying the duplications  displayed a non-wild-type subcellular distribution, with a marked enrichment at  the plasma membrane. This led to a striking degree of AKT1 activation  demonstrated by a strong phosphorylation level and corroborated by reporter  assays. Analysis by RNA-Seq pinpointed a series of differentially expressed  genes, involved in cytokine and hormone signaling and cell division-related  processes. Further analyses pointed to a possible dedifferentiation process and  suggested that most of the transcriptomic dysregulations might be mediated by a  limited set of transcription factors perturbed by AKT1 activation. These  results incriminate somatic mutations of AKT1 as major probably driver events  in the pathogenesis of JGCTs.</p>			
			
			
			
			
   <h1>Protein  kinase C</h1>
   <p>Protein kinase C, commonly abbreviated to <strong>PKC</strong> (EC  2.7.11.13), is a family of <a href="https://en.wikipedia.org/wiki/Protein_kinase" title="Protein kinase">protein kinase</a> <a href="https://en.wikipedia.org/wiki/Enzyme" title="Enzyme">enzymes</a> that are involved in controlling the function of other <a href="https://en.wikipedia.org/wiki/Protein" title="Protein">proteins</a> through the <a href="https://en.wikipedia.org/wiki/Phosphorylation" title="Phosphorylation">phosphorylation</a> of <a href="https://en.wikipedia.org/wiki/Hydroxyl" title="Hydroxyl">hydroxyl</a> groups of <a href="https://en.wikipedia.org/wiki/Serine" title="Serine">serine</a> and <a href="https://en.wikipedia.org/wiki/Threonine" title="Threonine">threonine</a> amino acid residues on these proteins, or a  member of this family. PKC enzymes in turn are activated by signals such as  increases in the concentration of <a href="https://en.wikipedia.org/wiki/Diacylglycerol" title="Diacylglycerol">diacylglycerol</a> (DAG) or <a href="https://en.wikipedia.org/wiki/Calcium" title="Calcium">calcium</a> ions (Ca2+). Hence PKC enzymes play important  roles in several <a href="https://en.wikipedia.org/wiki/Signal_transduction" title="Signal transduction">signal  transduction</a> cascades. The PKC family consists of fifteen <a href="https://en.wikipedia.org/wiki/Isozymes" title="Isozymes">isozymes</a> in humans. They are divided into three subfamilies,  based on their second messenger requirements: conventional (or classical),  novel, and atypical. Conventional (c)PKCs contain the <a href="https://en.wikipedia.org/wiki/Isoforms" title="Isoforms">isoforms</a> α, βI, βII, and γ. These require Ca2+, <a href="https://en.wikipedia.org/wiki/Diglyceride" title="Diglyceride">DAG</a>, and a <a href="https://en.wikipedia.org/wiki/Phospholipid" title="Phospholipid">phospholipid</a> such as <a href="https://en.wikipedia.org/wiki/Phosphatidylserine" title="Phosphatidylserine">phosphatidylserine</a> for activation. Novel (n)PKCs  include the δ, ε, η, and θ isoforms, and require DAG, but do not require Ca2+ for  activation. Thus, conventional and novel PKCs are activated through the  same <a href="https://en.wikipedia.org/wiki/Signal_transduction" title="Signal transduction">signal  transduction</a>pathway  as <a href="https://en.wikipedia.org/wiki/Phospholipase_C" title="Phospholipase C">phospholipase  C</a>. On the other hand,  atypical (a)PKCs (including <a href="https://en.wikipedia.org/wiki/Protein_kinase_M%CE%B6" title="Protein kinase Mζ">protein  kinase Mζ</a> and ι / λ  isoforms) require neither Ca2+ nor diacylglycerol for  activation. The term &quot;protein kinase C&quot; usually refers to the entire  family of isoforms.</p>
   <h2>1.0 Structure</h2>
   <p>The structure of all PKCs  consists of a regulatory domain and a catalytic domain tethered together by a  hinge region. The catalytic region is highly conserved among the different  isoforms, as well as, to a lesser degree, among the catalytic region of other <a href="https://en.wikipedia.org/wiki/Serine/threonine-specific_protein_kinase" title="Serine/threonine-specific protein kinase">serine/threonine kinases</a>. The second messenger requirement differences in  the isoforms are a result of the regulatory region, which are similar within  the classes, but differ among them. Most of the crystal structure of the  catalytic region of PKC has not been determined, except for PKC theta and iota.  Due to its similarity to other kinases whose crystal structure have been determined,  the structure can be strongly predicted.</p>
  
   <h3>1.1 Regulatory</h3>
   <p>The regulatory domain or the  amino-teminus of the PKCs contains several shared subregions. The C1 domain,  present in all of the isoforms of PKC has a binding site for DAG as well as  non-hydrolysable, non-physiological analogues called <a href="https://en.wikipedia.org/wiki/Phorbol_ester" title="Phorbol ester">phorbol esters</a>. This domain is functional and capable of binding  DAG in both conventional and novel isoforms, however, the C1 domain in atypical  PKCs is incapable of binding to DAG or phorbol esters. The C2 domain acts as a  Ca2+ sensor and is present in both conventional and novel  isoforms, but functional as a Ca2+ sensor only in the  conventional. The pseudosubstrate region, which is present in all three classes  of PKC, is a small sequence of amino acids that mimic a substrate and bind the  substrate-binding cavity in the catalytic domain,lack critical serine,  threonine phosphoacceptor residues, keeping the enzyme inactive. When Ca2+ and  DAG are present in sufficient concentrations, they bind to the C2 and C1  domain, respectively, and recruit PKC to the membrane. This interaction with  the membrane results in release of the pseudosubstrate from the catalytic site  and activation of the enzyme. In order for these allosteric interactions to  occur, however, PKC must first be properly folded and in the correct  conformation permissive for catalytic action. This is contingent upon  phosphorylation of the catalytic region, discussed below.</p>
  
   <h3>1.2 Catalytic</h3>
   <p>The catalytic region or  kinase core of the PKC allows for different functions to be processed; <a href="https://en.wikipedia.org/wiki/AKT" title="AKT">PKB</a> (also known as <a href="https://en.wikipedia.org/wiki/Akt" title="Akt">Akt</a>) and PKC kinases contains approximately 40% <a href="https://en.wikipedia.org/wiki/Amino_acid" title="Amino acid">amino acid</a> sequence similarity. This similarity  increases to ~ 70% across PKCs and even higher when comparing within classes.  For example, the two atypical PKC isoforms, ζ and ι/λ, are 84% identical  (Selbie et al., 1993). Of the over-30 protein kinase structures whose crystal  structure has been revealed, all have the same basic organization. They are a  bilobal structure with a β sheet comprising the N-terminal lobe and an α helix  constituting the C-terminal lobe. Both the <a href="https://en.wikipedia.org/wiki/Adenosine_triphosphate" title="Adenosine triphosphate">ATP</a>- and substrate-binding sites are located  in the cleft formed by these two lobes. This is also where the pseudosubstrate  domain of the regulatory region binds.[<a href="https://en.wikipedia.org/wiki/Wikipedia:Manual_of_Style" title="Wikipedia:Manual of Style"></a>] Another feature of the PKC  catalytic region that is essential to the viability of the kinase is its  phosphorylation. The conventional and novel PKCs have three phosphorylation  sites, termed: the <a href="https://en.wikipedia.org/wiki/Activation_loop" title="Activation loop">activation loop</a>, the <a href="https://en.wikipedia.org/wiki/Turn_(biochemistry)" title="Turn (biochemistry)">turn</a> motif, and the <a href="https://en.wikipedia.org/wiki/Hydrophobic" title="Hydrophobic">hydrophobic</a> motif. The atypical PKCs are phosphorylated  only on the activation loop and the turn motif. <a href="https://en.wikipedia.org/wiki/Phosphorylation" title="Phosphorylation">Phosphorylation</a> of the hydrophobic motif is rendered  unnecessary by the presence of a <a href="https://en.wikipedia.org/wiki/Glutamic_acid" title="Glutamic acid">glutamic acid</a> in place of a serine, which, as a negative  charge, acts similar in manner to a phosphorylated residue. These  phosphorylation events are essential for the activity of the enzyme, and  3-phosphoinositide-dependent protein kinase-1 (<a href="https://en.wikipedia.org/wiki/Pyruvate_dehydrogenase_lipoamide_kinase_isozyme_1" title="Pyruvate dehydrogenase lipoamide kinase isozyme 1">PDK1</a>) is the upstream kinase responsible for initiating the process by  transphosphorylation of the activation loop. The <a href="https://en.wikipedia.org/wiki/Consensus_sequence" title="Consensus sequence">consensus  sequence</a> of protein  kinase C enzymes is similar to that of <a href="https://en.wikipedia.org/wiki/Protein_kinase_A" title="Protein kinase A">protein kinase A</a>, since it contains <a href="https://en.wikipedia.org/wiki/Basic_(chemistry)" title="Basic (chemistry)">basic</a> amino acids close to the Ser/Thr to be  phosphorylated. Their substrates are, e.g., <a href="https://en.wikipedia.org/wiki/MARCKS_protein" title="MARCKS protein">MARCKS proteins</a>, <a href="https://en.wikipedia.org/wiki/MAP_kinase" title="MAP kinase">MAP kinase</a>, transcription factor inhibitor IκB, the <a href="https://en.wikipedia.org/wiki/Vitamin_D" title="Vitamin D">vitamin D</a>3 receptor <a href="https://en.wikipedia.org/wiki/Vitamin_D_receptor" title="Vitamin D receptor">VDR</a>, <a href="https://en.wikipedia.org/wiki/Raf_kinase" title="Raf kinase">Raf kinase</a>, <a href="https://en.wikipedia.org/wiki/Calpain" title="Calpain">calpain</a>, and the <a href="https://en.wikipedia.org/wiki/Epidermal_growth_factor_receptor" title="Epidermal growth factor receptor">epidermal growth factor receptor</a>.</p>
  
   <h2>2.0 Activation</h2>
   <p>Upon activation, protein  kinase C enzymes are translocated to the plasma membrane by <a href="https://en.wikipedia.org/wiki/RACK_protein" title="RACK protein">RACK proteins</a> (membrane-bound receptor for activated  protein kinase C proteins). The protein kinase C enzymes are known for their  long-term activation: They remain activated after the original activation  signal or the Ca2+-wave is gone. It is presumed that this is  achieved by the production of diacylglycerol from phosphatidylinositol by  a <a href="https://en.wikipedia.org/wiki/Phospholipase" title="Phospholipase">phospholipase</a>; fatty acids may also play a role in  long-term activation.</p>
   
   <h2>3.0 Function</h2>
   <p>A multiplicity of functions  has been ascribed to PKC. Recurring themes are that PKC is involved in receptor  desensitization, in modulating membrane structure events, in regulating  transcription, in mediating immune responses, in regulating cell growth, and in  learning and memory. These functions are achieved by PKC-mediated  phosphorylation of other proteins. However, the substrate proteins present for  phosphorylation vary, since protein expression is different between different  kinds of cells. Thus, effects of PKC are cell-type-specific:</p>
   <table class="mytable" border="1" cellspacing="0" cellpadding="0">
     <tr>
       <td width="149"><p align="center"><strong>Cell type</strong></p></td>
       <td width="115"><p align="center"><strong>Organ/system</strong></p></td>
       <td width="185"><p align="center"><strong>Activators<br>
       </strong><a href="https://en.wikipedia.org/wiki/Ligands" title="Ligands">ligands</a><strong>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/Gq_alpha_subunit" title="Gq alpha subunit">Gq</a>-</strong><a href="https://en.wikipedia.org/wiki/G-protein_coupled_receptor" title="G-protein coupled receptor">GPCRs</a><strong></strong></p></td>
       <td width="173"><p align="center"><strong>Effects</strong></p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Smooth_muscle" title="Smooth muscle">smooth    muscle</a>&nbsp;cell (<a href="https://en.wikipedia.org/wiki/Gastrointestinal_tract" title="Gastrointestinal tract">gastrointestinal tract</a>&nbsp;<a href="https://en.wikipedia.org/wiki/Sphincter" title="Sphincter">sphincters</a>)</p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Digestive_system" title="Digestive system">digestive    system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/Prostaglandin_F2alpha" title="Prostaglandin F2alpha">prostaglandin F2α</a>&nbsp;--&gt;</p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Thromboxane" title="Thromboxane">thromboxanes</a></p></td>
       <td width="173"><p align="center">contraction</p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Smooth_muscle" title="Smooth muscle">smooth    muscle</a>&nbsp;cells in:</p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Iris_dilator_muscle" title="Iris dilator muscle">iris dilator muscle</a>&nbsp;(<a href="https://en.wikipedia.org/wiki/Sensory_system" title="Sensory system">sensory    system</a>)</p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Urethral_sphincter" title="Urethral sphincter">urethral sphincter</a>&nbsp;(<a href="https://en.wikipedia.org/wiki/Urinary_system" title="Urinary system">urinary    system</a>)</p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Uterus" title="Uterus">uterus</a>&nbsp;(<a href="https://en.wikipedia.org/wiki/Reproductive_system" title="Reproductive system">reproductive system</a>)</p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Arrector_pili_muscles" title="Arrector pili muscles">arrector pili muscles</a>&nbsp;(<a href="https://en.wikipedia.org/wiki/Integumentary_system" title="Integumentary system">integumentary system</a>)</p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Ureter" title="Ureter">ureter</a>&nbsp;(<a href="https://en.wikipedia.org/wiki/Urinary_system" title="Urinary system">urinary    system</a>)</p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Urinary_bladder" title="Urinary bladder">urinary    bladder</a>&nbsp;(<a href="https://en.wikipedia.org/wiki/Urinary_system" title="Urinary system">urinary system</a>)</p></td>
       <td width="115"><p align="center">Various</p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/Adrenergic_agonist" title="Adrenergic agonist">adrenergic agonists</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/%CE%911_receptor" title="Α1 receptor">α1    receptor</a></p></td>
       <td width="173"><p align="center">contraction</p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Smooth_muscle" title="Smooth muscle">smooth    muscle</a>&nbsp;cells in:</p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Iris_constrictor_muscle" title="Iris constrictor muscle">iris constrictor muscle</a></p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Ciliary_muscle" title="Ciliary muscle">ciliary    muscle</a></p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Sensory_system" title="Sensory system">sensory    system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/Acetylcholine" title="Acetylcholine">acetylcholine</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/M3_receptor" title="M3 receptor">M3    receptor</a></p></td>
       <td width="173"><p align="center">contraction</p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Smooth_muscle" title="Smooth muscle">smooth    muscle</a>&nbsp;cell (vascular)</p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Circulatory_system" title="Circulatory system">circulatory system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/5-HT" title="5-HT">5-HT</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/5-HT2A_receptor" title="5-HT2A receptor">5-HT2A    receptor</a></p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Adrenergic_agonist" title="Adrenergic agonist">adrenergic agonists</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/%CE%911_receptor" title="Α1 receptor">α1    receptor</a></p></td>
       <td width="173"><p align="center"><a href="https://en.wikipedia.org/wiki/Vasoconstriction" title="Vasoconstriction">vasoconstriction</a></p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Smooth_muscle" title="Smooth muscle">smooth    muscle</a>&nbsp;cell (<a href="https://en.wikipedia.org/wiki/Seminal_tract" title="Seminal tract">seminal tract</a>)</p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Reproductive_system" title="Reproductive system">reproductive system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/Adrenergic_agonist" title="Adrenergic agonist">adrenergic agonists</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/%CE%911_receptor" title="Α1 receptor">α1    receptor</a></p></td>
       <td width="173"><p align="center"><a href="https://en.wikipedia.org/wiki/Ejaculation" title="Ejaculation">ejaculation</a></p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Smooth_muscle" title="Smooth muscle">smooth    muscle</a>&nbsp;cell (<a href="https://en.wikipedia.org/wiki/Gastrointestinal_tract" title="Gastrointestinal tract">GI tract</a>)</p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Digestive_system" title="Digestive system">digestive    system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/5-HT" title="5-HT">5-HT</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/5-HT2A_receptor" title="5-HT2A receptor">5-HT2A</a>&nbsp;or&nbsp;<a href="https://en.wikipedia.org/wiki/5-HT2B_receptor" title="5-HT2B receptor">5-HT2B    receptor</a></p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Acetylcholine" title="Acetylcholine">acetylcholine</a>&nbsp;(ACh)    --&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/M3_receptor" title="M3 receptor">M3 receptor</a></p></td>
       <td width="173"><p align="center">contraction</p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Smooth_muscle" title="Smooth muscle">smooth    muscle</a>&nbsp;cell (<a href="https://en.wikipedia.org/wiki/Bronchi" title="Bronchi">bronchi</a>)</p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Respiratory_system" title="Respiratory system">respiratory system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/5-HT" title="5-HT">5-HT</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/5-HT2A_receptor" title="5-HT2A receptor">5-HT2A    receptor</a></p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Adrenergic_agonist" title="Adrenergic agonist">adrenergic agonists</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/w/index.php?title=%CE%92%E2%82%82_receptor&action=edit&redlink=1" title="Β₂ receptor (page does not exist)">β₂ receptor</a></p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Acetylcholine" title="Acetylcholine">acetylcholine</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/M3_receptor" title="M3 receptor">M3</a><a href="https://en.wikipedia.org/wiki/Protein_kinase_C#cite_note-isbn0-07-142280-3-12">[12]</a>&nbsp;and&nbsp;<a href="https://en.wikipedia.org/wiki/M1_receptor" title="M1 receptor">M1    receptor</a><a href="https://en.wikipedia.org/wiki/Protein_kinase_C#cite_note-entrezM1-13">[13]</a></p></td>
       <td width="173"><p align="center"><a href="https://en.wikipedia.org/wiki/Bronchoconstriction" title="Bronchoconstriction">bronchoconstriction</a></p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Proximal_convoluted_tubule_cell" title="Proximal convoluted tubule cell">proximal convoluted tubule cell</a></p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Kidney" title="Kidney">kidney</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/Angiotensin_II" title="Angiotensin II">angiotensin    II</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/AT1_receptor" title="AT1 receptor">AT1 receptor</a></p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Adrenergic_agonist" title="Adrenergic agonist">adrenergic agonists</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/%CE%911_receptor" title="Α1 receptor">α1    receptor</a></p></td>
       <td width="173"><p align="center">stimulate&nbsp;<a href="https://en.wikipedia.org/wiki/NHE3" title="NHE3">NHE3</a>&nbsp;--&gt; H+&nbsp;secretion    &amp; Na+&nbsp;reabsorption<a href="https://en.wikipedia.org/wiki/Protein_kinase_C#cite_note-boron787-14">[14]</a></p>
         <p align="center">stimulate basolateral&nbsp;<a href="https://en.wikipedia.org/wiki/Na-K_ATPase" title="Na-K ATPase">Na-K    ATPase</a>&nbsp;--&gt; Na+&nbsp;reabsorption</p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Neurons" title="Neurons">neurons</a>&nbsp;in&nbsp;<a href="https://en.wikipedia.org/wiki/Autonomic_ganglia" title="Autonomic ganglia">autonomic ganglia</a></p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Nervous_system" title="Nervous system">nervous    system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/Acetylcholine" title="Acetylcholine">acetylcholine</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/M1_receptor" title="M1 receptor">M1    receptor</a></p></td>
       <td width="173"><p align="center"><a href="https://en.wikipedia.org/wiki/Excitatory_postsynaptic_potential" title="Excitatory postsynaptic potential">EPSP</a></p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Neurons" title="Neurons">neurons</a>&nbsp;in&nbsp;<a href="https://en.wikipedia.org/wiki/Central_nervous_system" title="Central nervous system">CNS</a></p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Nervous_system" title="Nervous system">nervous    system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/5-HT" title="5-HT">5-HT</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/5-HT2A_receptor" title="5-HT2A receptor">5-HT2A    receptor</a></p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Glutamate_(neurotransmitter)" title="Glutamate (neurotransmitter)">glutamate</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/NMDA_receptor" title="NMDA receptor">NMDA    receptor</a></p></td>
       <td width="173"><p align="center">neuronal excitation (5-HT)</p>
         <p align="center">memory (glutamate)</p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Platelet" title="Platelet">platelets</a></p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Circulatory_system" title="Circulatory system">circulatory system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/5-HT" title="5-HT">5-HT</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/5-HT2A_receptor" title="5-HT2A receptor">5-HT2A    receptor</a></p></td>
       <td width="173"><p align="center">aggregation</p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Ependymal_cell" title="Ependymal cell">ependymal    cells</a>&nbsp;(<a href="https://en.wikipedia.org/wiki/Choroid_plexus" title="Choroid plexus">choroid plexus</a>)</p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Ventricular_system" title="Ventricular system">ventricular system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/5-HT" title="5-HT">5-HT</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/5-HT2C_receptor" title="5-HT2C receptor">5-HT2C    receptor</a></p></td>
       <td width="173"><p align="center">↑<a href="https://en.wikipedia.org/wiki/Cerebrospinal_fluid" title="Cerebrospinal fluid">cerebrospinal fluid</a>&nbsp;secretion</p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Heart_muscle" title="Heart muscle">heart    muscle</a></p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Circulatory_system" title="Circulatory system">circulatory system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/Adrenergic_agonist" title="Adrenergic agonist">adrenergic agonists</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/%CE%921_receptor" title="Β1 receptor">β1    receptor</a></p></td>
       <td width="173"><p align="center">positive&nbsp;<a href="https://en.wikipedia.org/wiki/Ionotropic_effect" title="Ionotropic effect">ionotropic effect</a></p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Serous_cell" title="Serous cell">serous    cells</a>&nbsp;(<a href="https://en.wikipedia.org/wiki/Salivary_gland" title="Salivary gland">salivary gland</a>)</p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Digestive_system" title="Digestive system">digestive    system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/Acetylcholine" title="Acetylcholine">acetylcholine</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/M1_receptor" title="M1 receptor">M1</a>&nbsp;and&nbsp;<a href="https://en.wikipedia.org/wiki/M3_receptor" title="M3 receptor">M3    receptors</a></p>
         <p align="center"><a href="https://en.wikipedia.org/wiki/Adrenergic_agonist" title="Adrenergic agonist">adrenergic agonists</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/%CE%921_receptor" title="Β1 receptor">β1    receptor</a></p></td>
       <td width="173"><p align="center">↑secretion</p>
         <p align="center">salivary&nbsp;<a href="https://en.wikipedia.org/wiki/Potassium" title="Potassium">potassium</a>&nbsp;levels.</p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Serous_cell" title="Serous cell">serous    cells</a>&nbsp;(<a href="https://en.wikipedia.org/wiki/Lacrimal_gland" title="Lacrimal gland">lacrimal gland</a>)</p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Digestive_system" title="Digestive system">digestive    system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/Acetylcholine" title="Acetylcholine">acetylcholine</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/M3_receptor" title="M3 receptor">M3    receptor</a></p></td>
       <td width="173"><p align="center">↑secretion</p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Adipocyte" title="Adipocyte">adipocyte</a></p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Digestive_system" title="Digestive system">digestive    system</a>/<a href="https://en.wikipedia.org/wiki/Endocrine_system" title="Endocrine system">endocrine system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/Adrenergic_agonist" title="Adrenergic agonist">adrenergic agonists</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/w/index.php?title=%CE%923_receptor&action=edit&redlink=1" title="Β3 receptor (page does not exist)">β3 receptor</a></p></td>
       <td width="173"><p align="center"><a href="https://en.wikipedia.org/wiki/Glycogenolysis" title="Glycogenolysis">glycogenolysis</a>&nbsp;and&nbsp;<a href="https://en.wikipedia.org/wiki/Gluconeogenesis" title="Gluconeogenesis">gluconeogenesis</a></p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Hepatocyte" title="Hepatocyte">hepatocyte</a></p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Digestive_system" title="Digestive system">digestive    system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/Adrenergic_agonist" title="Adrenergic agonist">adrenergic agonists</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/%CE%911_receptor" title="Α1 receptor">α1    receptor</a></p></td>
       <td width="173"><p align="center"><a href="https://en.wikipedia.org/wiki/Glycogenolysis" title="Glycogenolysis">glycogenolysis</a>&nbsp;and&nbsp;<a href="https://en.wikipedia.org/wiki/Gluconeogenesis" title="Gluconeogenesis">gluconeogenesis</a></p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Sweat_gland" title="Sweat gland">sweat    gland</a>&nbsp;cells</p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Integumentary_system" title="Integumentary system">integumentary system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/Adrenergic_agonist" title="Adrenergic agonist">adrenergic agonists</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/%CE%922_receptor" title="Β2 receptor">β2    receptor</a></p></td>
       <td width="173"><p align="center">↑secretion</p></td>
     </tr>
     <tr>
       <td width="149"><p align="center"><a href="https://en.wikipedia.org/wiki/Parietal_cell" title="Parietal cell">parietal    cells</a></p></td>
       <td width="115"><p align="center"><a href="https://en.wikipedia.org/wiki/Digestive_system" title="Digestive system">digestive    system</a></p></td>
       <td width="185"><p align="center"><a href="https://en.wikipedia.org/wiki/Acetylcholine" title="Acetylcholine">acetylcholine</a>&nbsp;--&gt;&nbsp;<a href="https://en.wikipedia.org/wiki/M3_receptor" title="M3 receptor">M3    receptors</a><a href="https://en.wikipedia.org/wiki/Protein_kinase_C#cite_note-17">[17]</a></p></td>
       <td width="173"><p align="center">↑&nbsp;<a href="https://en.wikipedia.org/wiki/Gastric_acid" title="Gastric acid">gastric    acid</a>&nbsp;secretion</p></td>
     </tr>
   </table>
   
   <h2>4.0 Pathology</h2>
   <p>Protein kinase C, activated by tumor promoter <a href="https://en.wikipedia.org/wiki/Phorbol_ester" title="Phorbol ester">phorbol ester</a>, may phosphorylate potent activators of  transcription, and thus lead to increased expression of oncogenes, promoting cancer progression, or interfere with other phenomena.</p>
  
   <h3>4.1 Inhibitors</h3>
   <p>Protein kinase C inhibitors,  such as <a href="https://en.wikipedia.org/wiki/Ruboxistaurin" title="Ruboxistaurin">ruboxistaurin</a>, may potentially be beneficial in  peripheral <a href="https://en.wikipedia.org/wiki/Diabetic_nephropathy" title="Diabetic nephropathy">diabetic  nephropathy</a>. <a href="https://en.wikipedia.org/wiki/Chelerythrine" title="Chelerythrine">Chelerythrine</a> is a natural <em>selective</em> PKC  inhibitor. Other naturally occurring PKCIs are <a href="https://en.wikipedia.org/wiki/Miyabenol_C" title="Miyabenol C">miyabenol C</a>, <a href="https://en.wikipedia.org/wiki/Myricitrin" title="Myricitrin">myricitrin</a>, <a href="https://en.wikipedia.org/wiki/Gossypol" title="Gossypol">gossypol</a>. Other PKCIs : <a href="https://en.wikipedia.org/wiki/Verbascoside" title="Verbascoside">Verbascoside</a>, <a href="https://en.wikipedia.org/wiki/BIM-1" title="BIM-1">BIM-1</a>. <a href="https://en.wikipedia.org/wiki/Bryostatin_1" title="Bryostatin 1">Bryostatin 1</a> can act as a PKC inhibitor; It was  investigated for cancer.</p>
   
   <h3>4.2 Activators</h3>
   <p>The Protein kinase C  activator <a href="https://en.wikipedia.org/wiki/Ingenol_mebutate" title="Ingenol mebutate">ingenol mebutate</a>, derived from the plant <a href="https://en.wikipedia.org/wiki/Euphorbia_peplus" title="Euphorbia peplus">Euphorbia peplus</a>, is FDA-approved for the treatment of <a href="https://en.wikipedia.org/wiki/Actinic_keratosis" title="Actinic keratosis">actinic keratosis</a>.<a href="https://en.wikipedia.org/wiki/Bryostatin_1" title="Bryostatin 1"> Bryostatin 1</a> can act as a PKCe activator and as  of 2016 is being investigated for <a href="https://en.wikipedia.org/wiki/Alzheimer%27s_disease" title="Alzheimer's disease">Alzheimer's  disease</a>.</p>
	   
   </div>
   </div>
	   
	   
    
			
			
<div class="media">
   <img class="mr-3" src="http://placehold.it/90x90" alt="thumbnail">
   <div class="media-body">
      <h5 class="mt-0">Media heading</h5>
      Cras sit amet nibh libero, in gravida nulla. Nulla vel metus scelerisque ante sollicitudin. Cras purus odio, vestibulum in vulputate at, tempus viverra turpis. Fusce condimentum nunc ac nisi vulputate fringilla. Donec lacinia congue felis in faucibus.
   </div>
</div>
		
 
   
</section>	
  </div><!-- col-->	
	</div><!-- row-->
	</div><!-- container-fluid-->	




<section class="bridge mybackground">
  <div class="mycontainer">
    <h1>Bridge Background</h1>
  </div>
</section>  

	
<footer>
    <nav>
      <div class="mycontainer">
      <ul>
        <li><a href="#jumbotron">Jumbotron</a></li>
        <li><a href="#palette">Palette</a></li>
        <li><a href="#buttons">Buttons</a></li>
        <li><a href="#typography">Typography</a></li>
        <li><a href="#lists">Lists</a></li>
        <li><a href="#media">Media</a></li>
        <li><a href="#tables">Tables</a></li>
		</ul>
    </div>
    </nav>
</footer>  


<script src="js/jquery.slim.min.js"></script>
<script src="js/popper.min.js"></script>
<script src="js/bootstrap.min.js"></script>
</body>
</html>

